Publication date: Jul 21, 2026
The increasing demand for adolescent eating disorder services during and following the COVID-19 pandemic necessitated alternative treatment approaches. Traditional in-patient and daycare settings faced challenges, including resource limitations and geographical accessibility. To describe and evaluate the outcomes of the Hospital at Home (H@H) service, an innovative, virtual, intensive treatment programme designed to prevent in-patient admissions or shorten length of in-patient stay. A prospective cohort of 71 consecutive admissions from October 2021 to December 2024 was established. Data included percentage median body mass index (%mBMI), Eating Disorders Examination Questionnaire (EDE-Q), Children’s Global Assessment Scale (CGAS) and any readmissions for in-patient treatment within the following 6 months. Qualitative feedback was also sought from staff and a sample of patients and family members. Of the 71 admissions to H@H, only 9 (13%) required hospitalisation. Mean %mBMI increased significantly, from 82. 4% (s. d. 8. 17) on admission to 90. 07% (s. d. 9. 44) on discharge (p
Open Access PDF
| Concepts | Keywords |
|---|---|
| children and adolescents | |
| Eating disorders | |
| intensive treatment | |
| online | |
| service innovation |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | eating disorders |
| disease | MESH | COVID-19 pandemic |
| disease | MESH | included |
| drug | DRUGBANK | Etoperidone |